The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers
- 23 March 1990
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 263 (12) , 1653-1657
- https://doi.org/10.1001/jama.263.12.1653
Abstract
We conducted a population-based, case-control study of risk factors for first events of coronary heart disease in patients with high blood pressure. All subjects had hypertension treated with medication. The 248 cases presented with new coronary heart disease from 1982 through 1984, and the 737 controls were a probability sample of health maintenance organization patients free of coronary heart disease. The health maintenance organizations computerized pharmacy database identified recent stoppers - patients who did not fill their prescriptions regularly enough to be at least 80% compliant. After adjustment for potential confounding factors, subjects who had recently stopped using .beta.-blockers had a transient fourfold increase in the relative risk of coronary heart disease (relative risk, 4.5; 95% confidence interval, 1.1 to 18.5). The association was specific to .beta.-blockers but not diuretics. A withdrawal syndrome immediately following the cessation of .beta.-blocker use may be an acute precipitant of angina and myocardial infarction in hypertensive patients who have no prior history of coronary heart disease.This publication has 8 references indexed in Scilit:
- Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.BMJ, 1989
- Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressureJAMA, 1989
- CIRCADIAN VARIATION OF TOTAL ISCHAEMIC BURDEN AND ITS ALTERATION WITH ANTI-ANGINAL AGENTSThe Lancet, 1988
- Transient myocardial ischemia after abrupt withdrawal of antianginal therapy in chronic stable anginaThe American Journal of Cardiology, 1988
- The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon — studies with culture heart cellsJournal of Molecular Medicine, 1987
- EUROPEAN INFARCTION STUDY (EIS) - A SECONDARY PREVENTION STUDY WITH SLOW RELEASE OXPRENOLOL AFTER MYOCARDIAL-INFARCTION - MORBIDITY AND MORTALITY1984
- Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol.Circulation, 1981
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979